
Invicta Diagnostic Limited IPO
Invicta Diagnostic Limited IPO is a SME book building IPO. Issue size is 28.12 Cr. Price band is ₹80 to ₹85 per share. Minimum investment is ₹2.72 L. Lot size is 1600 shares. Open from 1 Dec 2025 to 3 Dec 2025. Allotment on 4 Dec 2025. Listing on 8 Dec 2025 at NSE. Managed by Socradamus Capital Pvt.Ltd. Registrar: Bigshare Services Pvt Ltd. Key details for GMP, subscription, price, allotment, and listing in one place.
Invicta Diagnostic Limited IPO overview
Invicta Diagnostic Limited IPO Key figures
Price band, lot, minimum application, and issue window at a glance.
Invicta Diagnostic Limited IPO important dates
Invicta Diagnostic Limited IPO lot size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 3,200 | ₹2,72,000 |
| S-HNI (Min) | 3 | 4,800 | ₹4,08,000 |
| S-HNI (UPI) | 3 | 4,800 | ₹4,08,000 |
| S-HNI (Max) | 7 | 11,200 | ₹9,52,000 |
| B-HNI (Min) | 8 | 12,800 | ₹10,88,000 |
About Invicta Diagnostic Limited IPO
From the company / RHP narrative.
Invicta Diagnostics Limited (trading as PC Diagnostics) is a Mumbai-based diagnostic services company specialising in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring:
A flagship hub in Thane West offering full-spectrum pathology and advanced radiology (PET CT, MRI)
Three additional hubs (Bhayandar, Byculla, Marol) providing specialised diagnostic services
Three spokes in Lower Parel, Sewri, and Kalwa focused on basic imaging (X-ray, ultrasound) and sample collection.
The company offers around 60 routine and 487 specialised pathology tests, plus about 96 basic and 130 advanced radiology tests.
Invicta Diagnostics provides a comprehensive suite of diagnostic services, which includes:
Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels
Specialised Tests: Covers molecular diagnostics, immunoassays, infectious disease markers (e.g., dengue, COVID-19), cancer markers, and genetic panels
Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres.
As of October 31, 2025, the company employed 157 permanent employees.
Competitive Strength:
Expanding presence in the Mumbai Metropolitan Region (“MMR”), specifically in the radiology sector;
A diagnostics provider that offers a one-stop solution at an affordable price.
Technical capability and technology with IT infrastructure;
Dedicated management team with significant industry experience; and
Implementation of the Hub and Spoke Model.
Objective of the issue
How the issuer plans to use IPO proceeds.
General Corporate purposes
Ratings & reviews
Community ratings and reviews — not financial advice.
No ratings yet — be the first to share your experience.
Follow the latest IPO & unlisted research on iOS and Android.
Documents & links
Prospectus, draft filings, and company site open in a new tab.
Registrar
Details about the registrar of the issue.
Issue details
Key details about the issue, including the face value, lot size, and minimum investment.
Related articles
Research posts and updates that reference this company or theme.
Follow the latest IPO & unlisted research on iOS and Android.